Cargando…
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
Distinguishing between patients with early stage, screen detected prostate cancer who must be treated from those that can be safely watched has become a major issue in prostate cancer care. Identification of molecular subtypes of prostate cancer has opened the opportunity for testing whether biomark...
Autores principales: | Brooks, James D., Wei, Wei, Hawley, Sarah, Auman, Heidi, Newcomb, Lisa, Boyer, Hilary, Fazli, Ladan, Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A., Carroll, Peter R., Gleave, Martin, Lance, Raymond, Lin, Daniel W., Nelson, Peter S., Thompson, Ian M., True, Lawrence D., Feng, Ziding, McKenney, Jesse K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501723/ https://www.ncbi.nlm.nih.gov/pubmed/26172920 http://dx.doi.org/10.1371/journal.pone.0132343 |
Ejemplares similares
-
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study
por: Eminaga, Okyaz, et al.
Publicado: (2016) -
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma
por: Chan, Emily, et al.
Publicado: (2022) -
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
por: Sahoo, Debashis, et al.
Publicado: (2018) -
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
por: Troyer, Dean A, et al.
Publicado: (2015) -
Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016)